Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore W Kurtz

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Hypertension (Dallas, Tex. : 1979)|July 14, 2010
Chlorthalidone: don't call it "thiazide-like" anymoreTheodore W Kurtz
Hypertension (Dallas, Tex. : 1979)|February 8, 2003
False claims of blood pressure-independent protection by blockade of the renin angiotensin aldosterone system?Theodore W Kurtz
Nature Clinical Practice. Cardiovascular Medicine|July 17, 2008
Beyond the classic angiotensin-receptor-blocker profileTheodore W Kurtz
The American Journal of Medicine|March 28, 2006
New treatment strategies for patients with hypertension and insulin resistanceTheodore W Kurtz
American Journal of Hypertension|April 9, 2013
When blockade of the renin-angiotensin system becomes a two-edged swordTheodore W Kurtz
Hypertension (Dallas, Tex. : 1979)|November 10, 2010
Genome-wide association studies will unlock the genetic basis of hypertension.: con side of the argumentTheodore W Kurtz
American Journal of Hypertension|August 9, 2014
John Laragh: scientific pioneerTheodore W Kurtz
Hypertension (Dallas, Tex. : 1979)|March 7, 2007
Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapiesMichal Pravenec, Theodore W Kurtz
American Journal of Hypertension|June 7, 2008
Molecule-specific effects of angiotensin II-receptor blockers independent of the renin-angiotensin systemTheodore W Kurtz, Michal Pravenec
Journal of Hypertension|December 23, 2004
Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin systemTheodore W Kurtz, Michal Pravenec
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Hypertension (Dallas, Tex. : 1979)|July 14, 2010
Chlorthalidone: don't call it "thiazide-like" anymoreTheodore W Kurtz
Hypertension (Dallas, Tex. : 1979)|February 8, 2003
False claims of blood pressure-independent protection by blockade of the renin angiotensin aldosterone system?Theodore W Kurtz
Nature Clinical Practice. Cardiovascular Medicine|July 17, 2008
Beyond the classic angiotensin-receptor-blocker profileTheodore W Kurtz
The American Journal of Medicine|March 28, 2006
New treatment strategies for patients with hypertension and insulin resistanceTheodore W Kurtz
American Journal of Hypertension|April 9, 2013
When blockade of the renin-angiotensin system becomes a two-edged swordTheodore W Kurtz
Hypertension (Dallas, Tex. : 1979)|November 10, 2010
Genome-wide association studies will unlock the genetic basis of hypertension.: con side of the argumentTheodore W Kurtz
American Journal of Hypertension|August 9, 2014
John Laragh: scientific pioneerTheodore W Kurtz
Hypertension (Dallas, Tex. : 1979)|March 7, 2007
Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapiesMichal Pravenec, Theodore W Kurtz
American Journal of Hypertension|June 7, 2008
Molecule-specific effects of angiotensin II-receptor blockers independent of the renin-angiotensin systemTheodore W Kurtz, Michal Pravenec
Journal of Hypertension|December 23, 2004
Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin systemTheodore W Kurtz, Michal Pravenec
Pageof 9